U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06972875) titled 'Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer' on April 28.
Brief Summary: This study is for men with prostate cancer who are experiencing hot flashes due to treatments that lower testosterone. Hot flashes can affect your quality of life and make it harder for patients to continue their treatment, so researchers want to find a better way to manage them. The study is testing a drug called fezolinetant, which might help reduce hot flashes without using hormones. Fezolinetant is a drug that is currently approved for the treatment of hot flashes in menopausal women.
Study Start Date: May, 2025
Study Type: INTERVENTI...